1 |
Dupilumab |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
051 [4] 51, 98, 160, 162 💬 |
2 |
Dupilumab (blinded) |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
098 [1] 98 💬 |
3 |
Dupilumab (open-label) |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
098 [1] 98 💬 |
4 |
Dupilumab 300mg solution for injection |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
051 [1] 51 💬 |
5 |
Dupilumab prefilled syringe |
Dupilumab |
[1] D10354 D10354 💬 |
IL4R [1] IL4R 💬 |
Cytokine-cytokine receptor interaction [8] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation |
160 [1] 160 💬 |